Wall Street Zen Downgrades GlucoTrack (NASDAQ:GCTK) to Strong Sell

GlucoTrack (NASDAQ:GCTK) was downgraded by analysts at Wall Street Zen to a “strong sell” rating in a research report issued to clients and investors on Saturday.

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of GlucoTrack in a research note on Tuesday, April 21st. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, GlucoTrack presently has a consensus rating of “Sell”.

GlucoTrack Stock Performance

Shares of GCTK stock opened at $0.49 on Friday. The company has a debt-to-equity ratio of 0.08, a quick ratio of 0.85 and a current ratio of 0.85. GlucoTrack has a 52-week low of $0.29 and a 52-week high of $14.14. The company has a market capitalization of $3.08 million, a PE ratio of -0.03 and a beta of 0.77. The business’s fifty day moving average is $0.48 and its 200 day moving average is $1.34.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the company. Ikarian Capital LLC bought a new position in shares of GlucoTrack during the fourth quarter valued at approximately $177,000. Boothbay Fund Management LLC purchased a new position in GlucoTrack during the 4th quarter valued at about $52,000. Finally, Bank of America Corp DE lifted its holdings in shares of GlucoTrack by 102,125.0% during the second quarter. Bank of America Corp DE now owns 4,089 shares of the company’s stock valued at $25,000 after purchasing an additional 4,085 shares during the last quarter. 10.92% of the stock is owned by hedge funds and other institutional investors.

GlucoTrack Company Profile

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc and changed its name to GlucoTrack, Inc in November 2021. GlucoTrack, Inc was founded in 2001 and is based in Rutherford, New Jersey.